Atlas Private Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Atlas Private Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-125	Closed	-$16K	–	436
2021 Q3	$16K	Hold	125	–	–	0.01%	393
2021 Q2	$22K	Hold	125	–	–	0.01%	348
2021 Q1	$21K	Hold	125	–	–	0.01%	368
2020 Q4	$21K	Buy	125 +65	+108%	+$9.68K	0.01%	329
2020 Q3	$9K	Hold	60	–	–	0.01%	404
2020 Q2	$7K	Buy	+60	New	+$6.63K	0.01%	462

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Atlas Private Wealth Advisors's JAZZ Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 125 shares — an estimated $16K sold.

Atlas Private Wealth Advisors first reported a position in JAZZ in Q2 2020 and held it in 6 quarters. The position peaked at $22K in Q2 2021. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

Atlas Private Wealth Advisors reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Atlas Private Wealth Advisors sold 125 Jazz Pharmaceuticals shares in Q4 2021, an estimated $16K.
Atlas Private Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q2 2020 and held it in 6 quarters.
Atlas Private Wealth Advisors's Jazz Pharmaceuticals position peaked at $22K in Q2 2021.
454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.